J9347 — Tremelimumab-actl 20 Mg/ml Intravenous Solution
$131,777
All-payer median here
$144,131
Cash / self-pay here
20
payer/plan-name variants
Median over current-blob negotiated rates (COALESCE of standard / median / min–max midpoint, $0.01–$5M sentinel guard). Payers are canonical-grouped where a mapping exists; unmapped regional-plan name variants may appear as separate rows.